Display options
Cite
Dumkow LE, Beuschel TS, Brandt KL. Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program. Infect Dis Ther. 2017;6(3):453-459doi: 10.1007/s40121-017-0168-8.
Dumkow, L. E., Beuschel, T. S., & Brandt, K. L. (2017). Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program. Infectious diseases and therapy, 6(3), 453-459. https://doi.org/10.1007/s40121-017-0168-8
Dumkow, Lisa E, et al. "Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program." Infectious diseases and therapy vol. 6,3 (2017): 453-459. doi: https://doi.org/10.1007/s40121-017-0168-8
Dumkow LE, Beuschel TS, Brandt KL. Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program. Infect Dis Ther. 2017 Sep;6(3):453-459. doi: 10.1007/s40121-017-0168-8. Epub 2017 Aug 29. PMID: 28853035; PMCID: PMC5595781.
Copy Download .nbib Format: NLM
Share it on

Infect Dis Ther. 2017 Sep;6(3):453-459. doi: 10.1007/s40121-017-0168-8. Epub 2017 Aug 29.

Expanding Antimicrobial Stewardship to Urgent Care Centers Through a Pharmacist-Led Culture Follow-up Program.

Infectious diseases and therapy

Lisa E Dumkow, Thomas S Beuschel, Kasey L Brandt

Affiliations

  1. Department of Pharmacy Services, Mercy Health Saint Mary's, Grand Rapids, Michigan, USA. [email protected].
  2. Department of Pharmacy Services, Mercy Health Saint Mary's, Grand Rapids, Michigan, USA.

PMID: 28853035 PMCID: PMC5595781 DOI: 10.1007/s40121-017-0168-8

Abstract

INTRODUCTION: Urgent care centers represent a high-volume outpatient setting where antibiotics are prescribed frequently but resources for antimicrobial stewardship may be scarce. In 2015, our pharmacist-led Emergency Department (ED) culture follow-up program was expanded to include two urgent care (UC) sites within the same health system. The UC program is conducted by ED and infectious diseases clinical pharmacists as well as PGY1 pharmacy residents using a collaborative practice agreement (CPA). The purpose of this study was to describe the pharmacist-led UC culture follow-up program and its impact on pharmacist workload.

METHODS: This retrospective, descriptive study included all patients discharged to home from UC with a positive culture from any site resulting between 1 January and 31 December 2016. Data collected included the culture type, presence of intervention, and proportion of interventions made under the CPA. Additionally, pharmacist workload was reported as the number of call attempts made, new prescriptions written, and median time to complete follow-up per patient. Data were reported using descriptive statistics.

RESULTS: A total of 1461 positive cultures were reviewed for antibiotic appropriateness as part of the UC culture follow-up program, with 320 (22%) requiring follow-up intervention. Culture types most commonly requiring intervention were urine cultures (25%) and sexually transmitted diseases (25%). A median of 15 min was spent per intervention, with a median of one call (range 1-6 calls) needed to reach each patient. Less than half of patients required a new antimicrobial prescription at follow-up.

CONCLUSION: A pharmacist-led culture follow-up program conducted using a CPA was able to be expanded to UC sites within the same health system using existing clinical pharmacy staff along with PGY1 pharmacy residents. Service expansion resulted in minimal increase in pharmacist workload. Adding UC culture follow-up services to an existing ED program can allow health systems to expand antimicrobial stewardship initiatives to satellite locations.

Keywords: Antimicrobial stewardship; Collaborative practice agreement; Culture follow-up; Pharmacist; Urgent care

References

  1. Pediatrics. 2017 Apr;139(4):null - PubMed
  2. J Pediatr Health Care. 2017 Mar - Apr;31(2):184-188 - PubMed
  3. Am J Health Syst Pharm. 2016 Mar 1;73(5 Suppl 1):S49-56 - PubMed
  4. Am J Health Syst Pharm. 2011 May 15;68(10):916-9 - PubMed
  5. Chemotherapy. 2005 Jul;51(4):171-6 - PubMed
  6. JAMA. 2016 May 3;315(17):1864-73 - PubMed
  7. Infect Dis Ther. 2014 Jun;3(1):45-53 - PubMed
  8. MMWR Recomm Rep. 2016 Nov 11;65(6):1-12 - PubMed
  9. J Pharm Pract. 2012 Apr;25(2):190-4 - PubMed
  10. J Hosp Med. 2011 Sep;6(7):405-10 - PubMed

Publication Types